Knoll Capital Management, LLC
MIAMI, FL · CIK 1325083 · 13F filing filed 2022-08-15
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyMiami, FL
$175.2m
reported value
+10.0% vs Q1 2022
41positions
89.1%in top 10
2 new
7 added
1 reduced
2 sold out
vs Q1 2022
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $131.4m75.00% | Unchanged |
| ALDEYRA THERAPEUTICS INC ALDX | $6.0m3.42% | Added +743.1k |
| EIGER BIOPHARMACEUTICALS INC CLDN | $4.4m2.50% | Unchanged |
| ENTERA BIO LTD ENTX | $3.3m1.89% | Unchanged |
| Orgenesis, Inc. COM | $3.2m1.82% | Unchanged |
| Anavex Life Sciemves Corp COM NEW | $2.1m1.20% | New |
| ALTIMMUNE INC ALT | $1.6m0.89% | Unchanged |
| BLACKSTONE GROUP L P BX | $1.5m0.83% | Unchanged |
| CVS HEALTH CORP CVS | $1.3m0.77% | Unchanged |
| ARISTA NETWORKS INC COM | $1.3m0.74% | Unchanged |
| CORBUS PHARMACEUTICALS HLDGS CRBP | $1.3m0.73% | Unchanged |
| BOOZ ALLEN HAMILTON HLDG COR BAH | $1.2m0.67% | Unchanged |
| THERMO FISHER SCIENTIFIC INC TMO | $1.1m0.65% | Unchanged |
| CENTURYLINK INC CTL | $1.1m0.62% | Unchanged |
| APPLIED THERAPEUTICS INC APLT | $1.0m0.59% | Unchanged |
| EQUINOX GOLD CORP EQX | $971.0k0.55% | Added +53.5k |
| VISA INC V | $955.0k0.55% | Unchanged |
| ALTRIA GROUP INC MO | $948.0k0.54% | Unchanged |
| SILVERCREST METALS INC SIL | $861.0k0.49% | Added +52.0k |
| PAN AMERN SILVER CORP PAAS | $849.0k0.48% | Added +13.2k |
| CORNING INC GLW | $838.0k0.48% | Unchanged |
| MAVERIX METALS INC COM NEW | $718.0k0.41% | Added +50.0k |
| AGNICO EAGLE MINES LTD AEM | $704.0k0.40% | Unchanged |
| OSHKOSH CORP OSK | $694.0k0.40% | Unchanged |
| OSISKO GOLD ROYALTIES LTD COM | $676.0k0.39% | Added +45.0k |
| FRANCO NEV CORP FNV | $645.0k0.37% | Added +1.1k |
| ADVANCED MICRO DEVICES INC AMD | $627.0k0.36% | Unchanged |
| ASML HOLDING N V ASML | $609.0k0.35% | Unchanged |
| WHEATON PRECIOUS METALS CORP WPM | $594.0k0.34% | New |
| MAG SILVER CORP MAG | $584.0k0.33% | Reduced -4.5k |
| ABEONA THERAPEUTICS INC COM | $461.0k0.26% | Unchanged |
| SEABRIDGE GOLD INC COM | $398.0k0.23% | Unchanged |
| MIRATI THERAPEUTICS INC MRTX | $336.0k0.19% | Unchanged |
| CONTEXT THERAPEUTICS INC CNTX | $296.0k0.17% | Unchanged |
| SOLIGENIX INC COM | $163.0k0.09% | Unchanged |
| ANNOVIS BIO INC ANVS | $161.0k0.09% | Unchanged |
| BIOXCEL THERAPEUTICS INC COM | $92.0k0.05% | Unchanged |
| ORAMED PHARMACEUTICALS INC ORMP | $92.0k0.05% | Unchanged |
| APPLIED GENETIC TECHNOLOGIES AGTC | $77.0k0.04% | Unchanged |
| ANGION BIOMEDICA CORP COM | $68.0k0.04% | Unchanged |
| SPERO THERAPEUTICS INC SPRO | $52.0k0.03% | Unchanged |
Sold out since Q1 2022
| Security | Value then |
|---|---|
| ANAVEX LIFE SCIENCES CORP AVXL | $2.6m210.8k shares |
| FIRST MAJESTIC SILVER CORP AG | $434.0k33.0k shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 | 5.3%≈ $4.7m |